Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2018

Open Access 01-12-2018 | Case report

Long-term follow-up in a Chinese child with congenital lipoid adrenal hyperplasia due to a StAR gene mutation

Authors: Xiu Zhao, Zhe Su, Xia Liu, Jianming Song, Yungen Gan, Pengqiang Wen, Shoulin Li, Li Wang, Lili Pan

Published in: BMC Endocrine Disorders | Issue 1/2018

Login to get access

Abstract

Background

Congenital lipoid adrenal hyperplasia (CLAH) is an extremely rare and the most severe form of congenital adrenal hyperplasia. Typical features include disorder of sex development, early-onset adrenal crisis and enlarged adrenal glands with fatty accumulation.

Case presentation

We report a case of CLAH caused by mutations in the steroidogenic acute regulatory protein (StAR) gene. The patient had typical early-onset adrenal crisis at 2 months of age. She had normal-appearing female genitalia and a karyotype of 46, XY. The serum cortisol and adrenal steroids levels were always nearly undetectable, but the adrenocorticotropic hormone levels were extremely high. Genetic analysis revealed compound heterozygous mutations at c. 229C > T (p.Q77X) in exon 3 and c. 722C > T (p.Q258X) in exon 7 of the StAR gene. The former mutation was previously detected in only two other Chinese CLAH patients. Both mutations cause truncation of the StAR protein. The case reported here appears to be a classic example of CLAH with very small adrenal glands and is the second reported CLAH case with small adrenal glands thus far. In a 15-year follow-up, the patient’s height was approximately average for females before age 4 and fell to − 1 SDS at 10 years of age. Her bone age was similar to her chronological age from age 4 to age 15 years.

Conclusions

In conclusion, this is a classic case of CLAH with exceptionally small adrenal glands. Q77X mutation seems to be more common in Chinese CLAH patients. Additionally, this is the first report of the growth pattern associated with CLAH after a 15-year follow-up.
Literature
1.
go back to reference Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL. Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol. 1985;23:481–93.CrossRef Hauffa BP, Miller WL, Grumbach MM, Conte FA, Kaplan SL. Congenital adrenal hyperplasia due to deficient cholesterol side-chain cleavage activity (20, 22-desmolase) in a patient treated for 18 years. Clin Endocrinol. 1985;23:481–93.CrossRef
2.
go back to reference Kaur J, Casas L, Bose HS. Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient. Endocrinol Diabetes Metab Case Rep. 2016;2016:150119.PubMedPubMedCentral Kaur J, Casas L, Bose HS. Lipoid congenital adrenal hyperplasia due to STAR mutations in a Caucasian patient. Endocrinol Diabetes Metab Case Rep. 2016;2016:150119.PubMedPubMedCentral
3.
go back to reference Lihong W, Lei W, Yanhua S, Qinfang W, Mei F, Gaixiu Z, et al. A case report of congenital lipoid adrenal hyperplasia and literature review. Chin J Med. 2017;52:92–6. Lihong W, Lei W, Yanhua S, Qinfang W, Mei F, Gaixiu Z, et al. A case report of congenital lipoid adrenal hyperplasia and literature review. Chin J Med. 2017;52:92–6.
4.
go back to reference Fu R, Lu L, Jiang J, Nie M, Wang X, Lu Z. A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia. Medicine (Baltimore). 2017;96:e6994.CrossRef Fu R, Lu L, Jiang J, Nie M, Wang X, Lu Z. A case report of pedigree of a homozygous mutation of the steroidogenic acute regulatory protein causing lipoid congenital adrenal hyperplasia. Medicine (Baltimore). 2017;96:e6994.CrossRef
5.
go back to reference Huang Z, Ye J, Han L, Qiu W, Zhang H, Yu Y, et al. Identification of five novel STAR variants in ten Chinese patients with congenital lipoid adrenal hyperplasia. Steroids. 2016;108:85–91.CrossRef Huang Z, Ye J, Han L, Qiu W, Zhang H, Yu Y, et al. Identification of five novel STAR variants in ten Chinese patients with congenital lipoid adrenal hyperplasia. Steroids. 2016;108:85–91.CrossRef
6.
go back to reference Xie T, Zheng JP, Huang YL, Fan C, Wu DY, Tan MY, et al. Clinical features and StAR gene mutations in children with congenital lipoid adrenal hyperplasia. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17:472–6.PubMed Xie T, Zheng JP, Huang YL, Fan C, Wu DY, Tan MY, et al. Clinical features and StAR gene mutations in children with congenital lipoid adrenal hyperplasia. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17:472–6.PubMed
7.
go back to reference Ruimin C, Xin Y, Ying Z, Xiaohong Y, Xiangquan L. Mutation analysis of steroid acute regulatory protein gene in a patient affected with congenital lipoid adrenal hyperplasia. Chinese J Endocrinol Metab. 2014;30:980–4. Ruimin C, Xin Y, Ying Z, Xiaohong Y, Xiangquan L. Mutation analysis of steroid acute regulatory protein gene in a patient affected with congenital lipoid adrenal hyperplasia. Chinese J Endocrinol Metab. 2014;30:980–4.
8.
go back to reference Shiqin L, Huicui Y, Linqi C, Wenxiang W, Haiying W, Fengyun WY, et al. case report of lipoid congenital adrenal hyperplasia. J Appl Clin Pediatr. 2010;25:263–4. Shiqin L, Huicui Y, Linqi C, Wenxiang W, Haiying W, Fengyun WY, et al. case report of lipoid congenital adrenal hyperplasia. J Appl Clin Pediatr. 2010;25:263–4.
9.
go back to reference Qiu WJ, Ye J, Han B, Han LS, Gu XF. Molecular genetic analysis of congenital lipoid adrenal hyperplasia. Zhonghua Er Ke Za Zhi. 2004;42:585–8.PubMed Qiu WJ, Ye J, Han B, Han LS, Gu XF. Molecular genetic analysis of congenital lipoid adrenal hyperplasia. Zhonghua Er Ke Za Zhi. 2004;42:585–8.PubMed
10.
11.
go back to reference Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47:487–92.PubMed Li H, Ji CY, Zong XN, Zhang YQ. Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years. Zhonghua Er Ke Za Zhi. 2009;47:487–92.PubMed
12.
go back to reference Houk CP, Lee PA. Consensus statement on terminology and management: disorders of sex development. Sex Dev. 2008;2:172–80.CrossRef Houk CP, Lee PA. Consensus statement on terminology and management: disorders of sex development. Sex Dev. 2008;2:172–80.CrossRef
13.
go back to reference Boehm U, Bouloux PM, Dattani MT, de Roux N, Dode C, Dunkel L, et al. Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547–64.CrossRef Boehm U, Bouloux PM, Dattani MT, de Roux N, Dode C, Dunkel L, et al. Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11:547–64.CrossRef
14.
go back to reference Lin D, Sugawara T, Strauss JR, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995;267:1828–31.CrossRef Lin D, Sugawara T, Strauss JR, Clark BJ, Stocco DM, Saenger P, et al. Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science. 1995;267:1828–31.CrossRef
15.
go back to reference Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, et al. structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry-Us. 1995;34:12506–12.CrossRef Sugawara T, Lin D, Holt JA, Martin KO, Javitt NB, Miller WL, et al. structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry-Us. 1995;34:12506–12.CrossRef
16.
go back to reference Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002;198:7–14.CrossRef Miller WL. Androgen biosynthesis from cholesterol to DHEA. Mol Cell Endocrinol. 2002;198:7–14.CrossRef
17.
go back to reference Kim JM, Choi JH, Lee JH, Kim GH, Lee BH, Kim HS, et al. High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. Eur J Endocrinol. 2011;165:771–8.CrossRef Kim JM, Choi JH, Lee JH, Kim GH, Lee BH, Kim HS, et al. High allele frequency of the p.Q258X mutation and identification of a novel mis-splicing mutation in the STAR gene in Korean patients with congenital lipoid adrenal hyperplasia. Eur J Endocrinol. 2011;165:771–8.CrossRef
18.
go back to reference Arakane F, Sugawara T, Nishino H, Liu Z, Holt JA, Pain D, et al. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A. 1996;93:13731–6.CrossRef Arakane F, Sugawara T, Nishino H, Liu Z, Holt JA, Pain D, et al. Steroidogenic acute regulatory protein (StAR) retains activity in the absence of its mitochondrial import sequence: implications for the mechanism of StAR action. Proc Natl Acad Sci U S A. 1996;93:13731–6.CrossRef
19.
go back to reference Kang E, Kim YM, Kim GH, Lee BH, Yoo HW, Choi JH. Mutation spectrum of STAR and a founder effect of the p.Q258* in Korean patients with congenital lipoid adrenal hyperplasia. Mol Med. 2017;23:149–54.CrossRef Kang E, Kim YM, Kim GH, Lee BH, Yoo HW, Choi JH. Mutation spectrum of STAR and a founder effect of the p.Q258* in Korean patients with congenital lipoid adrenal hyperplasia. Mol Med. 2017;23:149–54.CrossRef
20.
go back to reference Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N, Miller WL. Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85:3636–9.PubMed Bose HS, Sato S, Aisenberg J, Shalev SA, Matsuo N, Miller WL. Mutations in the steroidogenic acute regulatory protein (StAR) in six patients with congenital lipoid adrenal hyperplasia. J Clin Endocrinol Metab. 2000;85:3636–9.PubMed
21.
go back to reference Hashemipour M, Ghasemi M, Hovsepian S. a case of congenital lipoid adrenal hyperplasia. Int J Prev Med. 2012;3:510–4.PubMedPubMedCentral Hashemipour M, Ghasemi M, Hovsepian S. a case of congenital lipoid adrenal hyperplasia. Int J Prev Med. 2012;3:510–4.PubMedPubMedCentral
22.
go back to reference Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL. Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab. 2010;95:3352–9.CrossRef Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL. Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab. 2010;95:3352–9.CrossRef
23.
go back to reference Park HW, Kwak BO, Kim GH, Yoo HW, Chung S. P.R182C mutation in Korean twin with congenital lipoid adrenal hyperplasia. Ann Pediatr Endocrinol Metab. 2013;18:40–3.CrossRef Park HW, Kwak BO, Kim GH, Yoo HW, Chung S. P.R182C mutation in Korean twin with congenital lipoid adrenal hyperplasia. Ann Pediatr Endocrinol Metab. 2013;18:40–3.CrossRef
24.
go back to reference Khoury K, Barbar E, Ainmelk Y, Ouellet A, Lavigne P, LeHoux JG. Thirty-eight-year follow-up of two sibling lipoid congenital adrenal hyperplasia patients due to homozygous steroidogenic acute regulatory (STARD1) protein mutation. Molecular structure and modeling of the STARD1 L275P mutation. Front Neurosci. 2016;10:527.CrossRef Khoury K, Barbar E, Ainmelk Y, Ouellet A, Lavigne P, LeHoux JG. Thirty-eight-year follow-up of two sibling lipoid congenital adrenal hyperplasia patients due to homozygous steroidogenic acute regulatory (STARD1) protein mutation. Molecular structure and modeling of the STARD1 L275P mutation. Front Neurosci. 2016;10:527.CrossRef
25.
go back to reference Fluck CE, Pandey AV, Dick B, Camats N, Fernandez-Cancio M, Clemente M, et al. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One. 2011;6:e20178.CrossRef Fluck CE, Pandey AV, Dick B, Camats N, Fernandez-Cancio M, Clemente M, et al. Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One. 2011;6:e20178.CrossRef
Metadata
Title
Long-term follow-up in a Chinese child with congenital lipoid adrenal hyperplasia due to a StAR gene mutation
Authors
Xiu Zhao
Zhe Su
Xia Liu
Jianming Song
Yungen Gan
Pengqiang Wen
Shoulin Li
Li Wang
Lili Pan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2018
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-018-0307-6

Other articles of this Issue 1/2018

BMC Endocrine Disorders 1/2018 Go to the issue